Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Life (Basel) ; 12(9)2022 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-36143411

RESUMEN

Major cancer deaths can be ascribed to distant metastasis to which the assembly of pericellular fibronectin (periFN) on suspended tumor cells (STCs) in the bloodstream that facilitate endothelial attachment can lead. Even though mangosteen pericarps (MP) extracts and the major component α-mangostin (α-MG) exhibit potent cancer chemopreventive properties, whether they can prophylactically and therapeutically be used as dietary nutraceuticals to prevent distant metastasis by suppressing periFN assembly on STCs within the circulation remains obscure. Immunofluorescence staining, MTT assays, flow cytometric assays, immunoblotting, and experimental metastasis mouse models were used to detect the effects of MP extracts or α-MG on periFN on STCs, tumor cell proliferation and apoptosis, the AKT activity, and tumor lung metastasis. The periFN assembly on STCs was significantly diminished upon treatments of STCs with either α-MG or MP extracts in a dose-dependent manner without inhibiting cell proliferation and viability due to increased AKT activity. Pretreatment of STCs with α-MG appeared to suppress tumor lung metastasis and prolong mouse survival rates. Oral gavage with MP extracts could therapeutically, but not prophylactically, prevent lung metastasis of STCs. We concluded that MP extracts or the major component α-MG may therapeutically serve as a potent anti-metastatic nutraceutical.

2.
J Acquir Immune Defic Syndr ; 75 Suppl 3: S341-S345, 2017 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-28604436

RESUMEN

The rate of drug and opioid overdose deaths in the United States has more than tripled over the past 15 years. The ability to conduct public health surveillance on nonfatal overdoses is limited. The current study used National HIV Behavioral Surveillance (NHBS) data to estimate recent and lifetime history of nonfatal overdose events in persons who inject drugs in 7 cities. Recent and lifetime experience of overdose events ranged from 3% to 20% and from 29% to 63%, respectively. Adapting systems such as NHBS may be useful in responding to and monitoring emergent public health problems such as the overdose epidemic.


Asunto(s)
Ciudades , Sobredosis de Droga/epidemiología , Abuso de Sustancias por Vía Intravenosa/epidemiología , Adolescente , Adulto , Sistema de Vigilancia de Factor de Riesgo Conductual , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estados Unidos/epidemiología , Adulto Joven
3.
AIDS Behav ; 20(12): 2798-2811, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-26983950

RESUMEN

Men who have sex with men (MSM), particularly racial/ethnic minority MSM, are disproportionately affected by HIV in the United States and Texas. Bareback sex or condomless anal intercourse (CAI) can be a high HIV risk behavior. Despite this, a majority of MSM continues to engage in barebacking. Research suggests racial/ethnic differences in barebacking exist; however, these conclusions remain unclear due to insufficient sample sizes to compare racial/ethnic groups. Our cross-sectional correlational design explores barebacking correlates (substance use during sex, safe sex fatigue, and optimistic HIV treatment beliefs) within and between racial/ethnic groups among 366 MSM. Regression models are significant for Latino and African-American MSM alone and for all MSM combined, though not significant for European-American and Other Race/Ethnicity MSM alone. Our findings suggest motivations and behaviors underlying barebacking among MSM vary by racial/ethnic membership with clinical implications for informing culturally sensitive HIV interventions and prevention programs for target racial/ethnic groups.


Asunto(s)
Comparación Transcultural , Etnicidad/estadística & datos numéricos , Seronegatividad para VIH , Seropositividad para VIH/etnología , Homosexualidad Masculina/etnología , Conducta Sexual/etnología , Sexo Inseguro/etnología , Adolescente , Adulto , Anciano , Actitud Frente a la Salud , Estudios Transversales , Infecciones por VIH/prevención & control , Humanos , Masculino , Persona de Mediana Edad , Estadística como Asunto , Trastornos Relacionados con Sustancias/epidemiología , Texas , Estados Unidos , Adulto Joven
4.
Arch Pediatr Adolesc Med ; 165(8): 708-13, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21464373

RESUMEN

OBJECTIVE: To examine factors that may explain a 9-fold increase in plagiocephaly in Texas from 1999 to 2007. DESIGN: Descriptive epidemiologic study of time trends and a nested case-control study. SETTING: Texas. PARTICIPANTS: Cases in the Texas Birth Defects Registry. OUTCOME MEASURES: Time trends in the birth prevalence of plagiocephaly overall and by region, demographic group, and clinical subgroup. Trends in percentage of cases using specific facilities or procedures. RESULTS: From 1999 to 2007, the prevalence of plagiocephaly in Texas increased from 3.0 cases per 10 000 live births to 28.8, an average increase of 21.2% per year. This was highly statistically significant. The time trend was most pronounced in the Dallas/Fort Worth region and in certain health care facilities. It was observed in all demographic and clinical subgroups. Cases born in 2004 and 2005 were not more likely to be postnatally acquired when compared with cases born in 1999 and 2000. There was no commensurate decrease in other birth defects of the face or skull. CONCLUSIONS: A small part of the trend might have been due to delayed compliance with the infant supine sleeping recommendation and a slight increase in preterm births. It was not due to changes in birth defect coding practice or trends in multiple births, torticollis, or oligohydramnios. Because the plagiocephaly trend was observed mainly in patients visiting certain health care facilities, among mild cases, and among cases with minimally invasive procedures, we suspect it may be due mainly to changes in available therapies and insurance reimbursement practices.


Asunto(s)
Plagiocefalia/epidemiología , Estudios de Casos y Controles , Femenino , Humanos , Recién Nacido , Masculino , Prevalencia , Sistema de Registros , Factores de Riesgo , Texas/epidemiología
6.
Food Chem Toxicol ; 45(2): 303-14, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17030378

RESUMEN

SC-1, the aqueous phase of soybean fermentation products by bacteria (Bacillus subtilis and Bacillus brevis), significantly inhibited the growth and clonogenesity of human hepatocellular (Hep 3B), mouse hepatocellular (ML-1), and human colorectal (HCT 116 and HT-29) carcinoma cells. Cytotoxicity of SC-1 in Hep 3B cells was through the process of apoptosis characterizing by increase in cell population of sub-G(1) phase, fragmentation of DNA, and change of nuclear morphology. Treatment of Hep 3B cells with SC-1 activated caspase 8 and caspase 3. Elevation of nuclear DNA fragmentation factor 40 (DFF40) and cleavage form of poly(ADP-ribose) polymerase (PARP) were also observed. SC-1 also activated intrinsic pathway via increase of pro-apoptotic (tBid, Bak and Bax) and decrease of anti-apoptotic (Bcl-2 and Bcl-x(L)) proteins on mitochondria, disruption of mitochondrial membrane potential, release of cytochrome c and Smac (second mitochondria-derived activator of caspase/direct IAP binding protein with low PI) from mitochondria, and activation of caspase 9. Inhibition on protein expression of Ku70 in cytosol and cyclooxygenase (COX)-2, but not COX-1, in whole cell lystes were revealed in SC-1-treated Hep 3B cells. These results suggest caspase 8, Ku70 and mitochondria are involved in the antitumor mechanism of SC-1 in Hep 3B cells.


Asunto(s)
Apoptosis/efectos de los fármacos , Bacillus/metabolismo , Caspasa 8/metabolismo , Glycine max/química , Mitocondrias/metabolismo , Animales , Bacillus subtilis/metabolismo , Carcinoma Hepatocelular/patología , Caspasa 8/efectos de los fármacos , Línea Celular Tumoral , Ciclooxigenasa 2/metabolismo , Fragmentación del ADN , Activación Enzimática , Fermentación , Fase G1/efectos de los fármacos , Células HCT116 , Células HT29 , Humanos , Neoplasias Hepáticas/patología , Ratones , Mitocondrias/efectos de los fármacos , Proteínas Mitocondriales/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA